Variability of Nt-proANP and C-ANP

European Journal of Clinical Investigation

Volumn 32, Issue 8, 2002, Pages 545-548

  McDowell, G ^a   Patterson, C ^b   Maguire, S ^a   Shaw, C ^a   Nicholls, D P ^a   Hall, C ^c  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Atrial natriuretic peptide; Chronic cardiac failure; Chronobiology; N terminal pro atrial natriuretic peptide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; PEPTIDE; PROTEIN; PROTEIN NT PROANP; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD ANALYSIS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FOREARM; HEART FAILURE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RADIOIMMUNOASSAY; TIME;

AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RADIOIMMUNOASSAY; STATISTICS, NONPARAMETRIC;

EID: 0036997993     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.01031.x     Document Type: Article

References (18)

1. De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 1981;28:89-94.
2. 126 is the major storage form of rat atrial natriuretic peptide. Biochem J 1987;241:265-72.
3. Sundsfjord JA, Thibault G, Larochelle P, Cantin M. Identification and plasma concentration of the N-terminal fragment of pro-atrial natriuretic factor in man. J Clin Endocrinol Metab 1988;66:605-10.
4. 2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life. Peptides 1988;9:47-53.
5. Itoh H, Nakao K, Sugawara A, Saito Y, Mukoyama M, Morii N et al. γ-Atrial natriuretic peptide (γ-ANP)-derived peptides in human plasma: co-secretion of N-terminal γ-ANP fragment and α-ANP. J Clin Endocrinol Metab 1988;67:429-37.
6. Nugent AM, Onuoha GN, McEneaney DJ, Steelle IC, Hunter SJ, Prasanna K et al. Variability of atrial natriuretic peptide secretion in man. Eur J Clin Invest 1994;24:267-74.
7. Pedersen EB, Pedersen HB, Jensen KT. Pulsatile secretion of atrial natriuretic peptide and brain natriuretic peptide in healthy humans. Clin Sci 1999;97:201-6.
8. Winters CJ, Sallman AL, Baker BJ, Meadows J, Rico DM, Vesely DL et al. The N-terminus and 4000 mw peptide from the midportion of the N-terminal of atrial natriuretic factor prohormone each circulate in human plasma and increase in congestive cardiac failure. Circulation 1989;80:438-49.
9. 99-126 as diagnostic markers of atrial distension in patients with cardiac disease. Scand J Clin Invest 1993;53:41-9.
10. 99-126 in health and disease in an elderly population. Eur Heart J 1993;14:1508-13.
11. Hall C, Rouleau JL, Moye L, de Champlain J, Bichet D, Klein M et al. N-terminal pro-atrial natriuretic factor. An independent predictor of long term prognosis after myocardial infarction. Circulation 1994;89:1934-42.
12. Onuoha GN, Shaw C, Nicholls DP. Extraction of human alpha atrial natriuretic peptide and its physiological validation. Int Heart J 1998;65:23-31.
13. Merriam GR, Wachter KW. Algorithms for the study of episodic hormone secretion. Am J Physiol 1982;243:E310-18.
14. Zelis R, Flaim SF. Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 1982;24:437-59.
15. Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC. Atrial stretch, not pressure, is the principal determinant controlling the release of atrial natriuretic factor. Circ Res 1988;62:191-5.
16. McDowell G, Cave M, Bainbridge A et al. Is the secretion of atrial natriuretic peptide in man under neural control? Eur Heart J 2000;21:498-503.
17. Talwar S, Downie PF, Ng LL, Squire IB. Towards a blood test for heart failure: the potential use of circulating natriuretic peptides. Br J Clin Pharmacol 2000;50:15-20.
18. Dickstein K, Aarsland T, Hall C. Plasma N-terminal atrial natriuretic factor: a predictor of survival in patients with congestive heart failure. J Cardiac Failure 1997;3:83-9.